JP2006087345A - Fermented product obtained from eggplant - Google Patents
Fermented product obtained from eggplant Download PDFInfo
- Publication number
- JP2006087345A JP2006087345A JP2004276725A JP2004276725A JP2006087345A JP 2006087345 A JP2006087345 A JP 2006087345A JP 2004276725 A JP2004276725 A JP 2004276725A JP 2004276725 A JP2004276725 A JP 2004276725A JP 2006087345 A JP2006087345 A JP 2006087345A
- Authority
- JP
- Japan
- Prior art keywords
- fermentation
- eggplant
- fermented product
- fermented
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000061458 Solanum melongena Species 0.000 title claims abstract description 77
- 235000002597 Solanum melongena Nutrition 0.000 title claims abstract description 77
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 100
- 241000894006 Bacteria Species 0.000 claims abstract description 51
- 239000004310 lactic acid Substances 0.000 claims abstract description 50
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 50
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 244000005700 microbiome Species 0.000 claims abstract description 23
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 20
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 20
- 102000004366 Glucosidases Human genes 0.000 claims abstract description 6
- 108010056771 Glucosidases Proteins 0.000 claims abstract description 6
- 102000004190 Enzymes Human genes 0.000 claims description 27
- 108090000790 Enzymes Proteins 0.000 claims description 27
- 238000000855 fermentation Methods 0.000 abstract description 115
- 230000004151 fermentation Effects 0.000 abstract description 115
- 230000001766 physiological effect Effects 0.000 abstract description 22
- 102100024295 Maltase-glucoamylase Human genes 0.000 abstract description 19
- 108010028144 alpha-Glucosidases Proteins 0.000 abstract description 19
- 239000002994 raw material Substances 0.000 abstract description 10
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 60
- 239000000047 product Substances 0.000 description 56
- 239000000463 material Substances 0.000 description 30
- 238000005259 measurement Methods 0.000 description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 238000000034 method Methods 0.000 description 27
- 229940088598 enzyme Drugs 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 20
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 20
- 230000000694 effects Effects 0.000 description 15
- 235000000346 sugar Nutrition 0.000 description 15
- 230000005764 inhibitory process Effects 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- -1 endoarabanase Proteins 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000015165 citric acid Nutrition 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 229920001542 oligosaccharide Polymers 0.000 description 8
- 238000006386 neutralization reaction Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000012085 test solution Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 150000002482 oligosaccharides Chemical class 0.000 description 6
- 241001608472 Bifidobacterium longum Species 0.000 description 5
- 240000006024 Lactobacillus plantarum Species 0.000 description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 5
- 229940009291 bifidobacterium longum Drugs 0.000 description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 description 5
- 235000019629 palatability Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 101710130006 Beta-glucanase Proteins 0.000 description 4
- 241000194032 Enterococcus faecalis Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000192001 Pediococcus Species 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 4-nitrophenyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 240000001929 Lactobacillus brevis Species 0.000 description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229940032049 enterococcus faecalis Drugs 0.000 description 3
- 108010093305 exopolygalacturonase Proteins 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 244000283763 Acetobacter aceti Species 0.000 description 1
- 235000007847 Acetobacter aceti Nutrition 0.000 description 1
- 241000589212 Acetobacter pasteurianus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 101100256850 Drosophila melanogaster EndoA gene Proteins 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000500332 Tetragenococcus halophilus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- KBGAYAKRZNYFFG-BOHATCBPSA-N aceneuramic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](NC(=O)C)[C@@H](O)[C@H](O)[C@H](O)CO KBGAYAKRZNYFFG-BOHATCBPSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008618 cell wall macromolecule catabolic process Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940016409 methylsulfonylmethane Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明は、ナスに微生物を作用させることにより得られる発酵物、特にナスを発酵することによって様々な生理作用を有する発酵物に関する。 The present invention relates to a fermented material obtained by allowing microorganisms to act on eggplant, and particularly to a fermented material having various physiological effects by fermenting eggplant.
微生物を用いた発酵は、古くから用いられている加工技術の一つであって、例えば、動植物由来の原料に微生物を作用させることによって、原料の嗜好性の向上、および特定の物質や新たな有用物質の生産に利用されてきた。 Fermentation using microorganisms is one of the processing techniques that have been used for a long time. For example, by causing microorganisms to act on raw materials derived from animals and plants, the palatability of raw materials can be improved, and certain substances and new materials can be used. It has been used to produce useful substances.
近年においては、発酵することによって単に有用物質の産生や嗜好性を改善するだけでなく、新たな生理活性の獲得、具体例としては、発酵前の原料よりも生理活性を増強する作用を有するなど、生理活性の高い発酵物自身についての検討がなされている。(例えば特許文献1〜3)
しかし、用いる原料、原料の処理方法、および用いる微生物等によっては、発酵物が生理活性を有するとは限らないばかりか、発酵すらしないこともあるといった問題点がある。つまり、生理活性の高い発酵物を得るために発酵させても、その発酵における方法および素材の選択が誤っていれば、生理活性が低いまたは生理活性を有さない発酵物しか得られないという問題点がある。 However, depending on the raw material used, the raw material processing method, the microorganism used, etc., there is a problem that the fermented product does not always have physiological activity, and may not even be fermented. In other words, even if fermentation is performed to obtain a fermented product with high physiological activity, if the method and material in the fermentation are wrongly selected, only a fermented product with low or no physiological activity can be obtained. There is a point.
本発明は、上記問題点に鑑みてなされたものであって、その目的は、生理活性の高い発酵物と、その発酵物を用いた経口用組成物および経皮用組成物とを提供することにある。 The present invention has been made in view of the above problems, and its object is to provide a fermented product having high physiological activity, and an oral composition and a transdermal composition using the fermented product. It is in.
本発明者は、動植物原料へ微生物を作用させて得られる発酵物について鋭意検討を行ったところ、ナスを微生物で発酵して、優れた生理活性を有する発酵物を得ることができることを見出し、本発明に至った。 The present inventor conducted intensive studies on fermented products obtained by allowing microorganisms to act on animal and plant raw materials, and found that fermented products having excellent physiological activity can be obtained by fermenting eggplant with microorganisms. Invented.
すなわち、本発明の発酵物は、ナスに微生物を作用させることにより得られる発酵物であって、酵素阻害活性を有することを特徴としている。 That is, the fermented product of the present invention is a fermented product obtained by allowing a microorganism to act on eggplant, and is characterized by having enzyme inhibitory activity.
好ましくは、上記微生物は乳酸菌である。 Preferably, the microorganism is a lactic acid bacterium.
さらに好ましくは、上記発酵物は、チロシナーゼ阻害活性およびグルコシダーゼ阻害活性のうちの少なくともいずれかの酵素阻害活性を有する。 More preferably, the fermented product has an enzyme inhibitory activity of at least one of tyrosinase inhibitory activity and glucosidase inhibitory activity.
また、本発明の経口用組成物は、上記発酵物を含有することを特徴としている。 Moreover, the composition for oral use of this invention is characterized by containing the said fermented material.
さらに、本発明の経皮用組成物は、上記発酵物を含有することを特徴としている。 Furthermore, the transdermal composition of the present invention is characterized by containing the fermented product.
本発明によれば、所定の条件下でナスに微生物を作用させると、チロシナーゼ阻害活性、グルコシダーゼ阻害活性(例えばα−グルコシダーゼ阻害活性)といった生理活性を有する発酵物を得ることができる。例えば、微生物として乳酸菌を用いれば、生理活性の高い発酵物を得ることができる。さらに、その発酵物を用いれば、美容効果等を有する経口用組成物および経皮用組成物を得ることができる。 According to the present invention, when a microorganism is allowed to act on eggplant under predetermined conditions, a fermented product having physiological activities such as tyrosinase inhibitory activity and glucosidase inhibitory activity (for example, α-glucosidase inhibitory activity) can be obtained. For example, if a lactic acid bacterium is used as a microorganism, a fermented product with high physiological activity can be obtained. Furthermore, if the fermented product is used, an oral composition and a transdermal composition having a cosmetic effect and the like can be obtained.
以下、本発明の発酵物について説明する。なお、以下に説明する形態は、本発明を限定するものでない。すなわち、本発明は、本発明の趣旨の範囲内で種々改変することができる。 Hereinafter, the fermented product of the present invention will be described. In addition, the form demonstrated below does not limit this invention. That is, the present invention can be variously modified within the scope of the gist of the present invention.
(ナス)
ナス(茄子)は、ナス科の植物であり、全国各地で栽培され、日本では180種類以上にも及ぶ。品種としては、例えば、京都の椀ぎ、東北の民田、大芹川、巾着、大阪丸、千成、真黒、橘田、大阪中長、千両ナス、水ナス、大阪長、大仙長、熊本長、津田長、仙台長、河辺長などがある。このようナスの皮には、ポリフェノールが含まれ、抗酸化作用を有することも明らかとなってきている。なお、本発明においては、ナス科植物の果実を用いることが好ましい。
(eggplant)
Eggplant is a solanaceous plant, cultivated in various parts of the country, and over 180 kinds in Japan. Examples of varieties include Kyoto rowing, Tohoku mineda, Oyodogawa, drawstring, Osaka Maru, Sensei, Makuguro, Tachibana, Osaka Chucho, Senjou eggplant, Mizu eggplant, Osaka chief, Daisencho, Kumamoto chief, Tsuda Head, Sendai, and Kawabe. It has also become clear that eggplant skin contains polyphenols and has an antioxidant effect. In the present invention, it is preferable to use a fruit of a solanaceous plant.
本発明の発酵物を得る場合、通常、洗浄後のナスを、または、洗浄後にさらにカット・摩砕などの当業者が通常行う方法によって破砕したナスを用いる。破砕したナスを用いる場合、その破砕物の大きさに特に制限はないが、好ましくは、粒経が5000μm以下、より好ましくは20μm〜5000μm程度の破砕物が用いられる。 When the fermented product of the present invention is obtained, eggplant after washing is usually used, or eggplant crushed by a method usually performed by those skilled in the art such as cutting and grinding after washing. When the crushed eggplant is used, the size of the crushed material is not particularly limited, but a crushed material having a particle size of 5000 μm or less, more preferably about 20 μm to 5000 μm is preferably used.
本発明においては、破砕後、固液分離して得られた溶液(搾汁)も破砕物として用いることもできる。さらに、上記ナスまたはその破砕物を抽出した後、固液分離して用いてもよい。なお、ナス由来の成分、すなわち不溶性成分および水溶性成分の全ての成分を発酵することができる点では、ナスまたはその破砕物を固液分離せずに用いることが好ましい。 In the present invention, a solution (squeezed juice) obtained by solid-liquid separation after crushing can also be used as a crushed product. Furthermore, after extracting the eggplant or its crushed material, it may be used after solid-liquid separation. It should be noted that eggplant or its crushed material is preferably used without solid-liquid separation in terms of being able to ferment all components derived from eggplant, that is, insoluble components and water-soluble components.
上記ナスおよびその破砕物は、雑菌の繁殖を防ぐ目的で、加熱処理が施されてもよく、冷凍保存されてもよい。特に、冷凍保存は、ナスに含有される成分および風味の保持の観点から好ましく、直ちに次工程を行わない場合に採用される。 The eggplant and its crushed material may be heat-treated or stored frozen for the purpose of preventing the propagation of various bacteria. In particular, frozen storage is preferable from the viewpoint of maintaining components and flavor contained in eggplant, and is employed when the next step is not performed immediately.
上記ナスまたはその破砕物には、発酵を効率的に行うために、必要に応じて、加水されてもよい。加水量には、特に制限はない。例示すれば、ナスまたはその破砕物1質量部に対して、加える水の量の下限値は0.1質量部以上、好ましくは0.5質量部以上、加える水の量の上限値は30質量部以下、好ましくは10質量部以下とすればよい。 In order to perform fermentation efficiently, the eggplant or the crushed product thereof may be added with water as necessary. There is no restriction | limiting in particular in the amount of water. For example, the lower limit of the amount of water to be added is 0.1 parts by mass or more, preferably 0.5 parts by mass or more, and the upper limit of the amount of water to be added is 30 parts by mass with respect to 1 part by mass of eggplant or its crushed material. Or less, preferably 10 parts by mass or less.
(酵素処理工程および中和処理工程)
次に、ナスまたはその破砕物の発酵を促進するための工程について説明する。このような発酵を促進するための工程としては、例えば、酵素による細胞壁分解処理工程、中和処理工程が挙げられる。なお、この工程は、上記細胞壁分解処理工程および中和処理工程のいずれか1種だけ用いてもよいし、両方を用いてもよい。
(Enzyme treatment process and neutralization process)
Next, the process for promoting the fermentation of eggplant or its crushed material will be described. Examples of the process for promoting such fermentation include a cell wall decomposing process using an enzyme and a neutralizing process. In addition, this process may use only 1 type of the said cell wall decomposition | disassembly process process and a neutralization process process, and may use both.
酵素による細胞壁分解処理工程において、用いることができる酵素としては、例えば、アミラーゼ、ペクチナーゼ、エンドアラバナーゼ、セルラーゼ、ヘミセルラーゼ、エンドβ−グルカナーゼ、エキソβ−グルカナーゼ、キシラーゼ、β−グルコシダーゼなどが挙げられる。そのうち、ペクチナーゼを用いることが好ましい。もちろん、上記酵素を混合して用いてもよい。特に好ましくは、ペクチナーゼと、アミラーゼ、エンドアラバナーゼ、エンドβ−グルカナーゼ、エキソβ−グルカナーゼ、キシラナーゼ、およびβ−グルコシダーゼからなる群より選択される少なくとも1種の酵素との混合酵素である。これらの添加量は、酵素の種類によって異なるが、通常、酵素濃度が、0.0001〜0.5質量/容量%、好ましくは0.0005〜0.3質量/容量%となるように添加される。 Examples of the enzyme that can be used in the cell wall degradation treatment step with an enzyme include amylase, pectinase, endoarabanase, cellulase, hemicellulase, endo β-glucanase, exo β-glucanase, xylase, β-glucosidase and the like. . Of these, pectinase is preferably used. Of course, you may mix and use the said enzyme. Particularly preferred is a mixed enzyme of pectinase and at least one enzyme selected from the group consisting of amylase, endoarabanase, endo β-glucanase, exo β-glucanase, xylanase, and β-glucosidase. The amount of addition varies depending on the type of enzyme, but is usually added so that the enzyme concentration is 0.0001 to 0.5 mass / volume%, preferably 0.0005 to 0.3 mass / volume%. The
酵素処理の条件は、処理するナスの形状、酵素の種類、酵素濃度に応じて適宜設定すればよい。例えば、酵素処理における温度は、その下限値を30℃以上、好ましくは35℃以上とすればよく、その上限値を75℃以下、好ましくは70℃以下とすればよい。酵素処理における時間(酵素反応の時間)は、例えば、その下限値を30分間以上、好ましくは1時間以上、その上限値を72時間以下、好ましくは48時間以下とすればよい。 The enzyme treatment conditions may be set as appropriate according to the shape of the eggplant to be treated, the type of enzyme, and the enzyme concentration. For example, the lower limit of the temperature in the enzyme treatment may be 30 ° C or higher, preferably 35 ° C or higher, and the upper limit may be 75 ° C or lower, preferably 70 ° C or lower. The time for enzyme treatment (enzyme reaction time) may be, for example, a lower limit of 30 minutes or longer, preferably 1 hour or longer, and an upper limit of 72 hours or shorter, preferably 48 hours or shorter.
酵素処理を行えば、例えば、発酵の阻害要因(例えば、ペクチン等の細胞壁を構成する多糖類)を分解することができ、その結果、発酵を短時間で終了させることができる。このように発酵を短時間で終了させることができれば、例えば、発酵により損失させたくない成分(例えばアスコルビン酸など)がある場合は、そのような成分の損失を最小限とすることが可能となる。具体例でいえば、発酵による損失(例えばアスコルビン酸の損失)が少ないナスの発酵物を得ることができる。 When the enzyme treatment is performed, for example, a fermentation inhibiting factor (for example, a polysaccharide constituting a cell wall such as pectin) can be decomposed, and as a result, the fermentation can be completed in a short time. Thus, if fermentation can be completed in a short time, for example, when there is a component (such as ascorbic acid) that is not desired to be lost by fermentation, the loss of such component can be minimized. . As a specific example, it is possible to obtain a fermented eggplant with less loss due to fermentation (for example, loss of ascorbic acid).
さらに、例えば、酵素処理により多糖類が分解されれば、多糖類の分解物(単糖類、オリゴ糖など)が生成される。これらは、得られるナスの発酵物中における新たな成分となる。例えば、オリゴ糖は、整腸作用、発酵物の可溶化を促進するなどの様々な効果を有する。単糖類は、さらに微生物の増殖に必要な栄養素となり、微生物の有用物質の産生を促進すると考えられる。 Furthermore, for example, when a polysaccharide is decomposed by an enzyme treatment, a degradation product (monosaccharide, oligosaccharide, etc.) of the polysaccharide is generated. These become new components in the fermented eggplant obtained. For example, oligosaccharides have various effects such as intestinal regulation and promoting solubilization of fermented products. Monosaccharides are thought to further become nutrients necessary for the growth of microorganisms and promote the production of useful substances of microorganisms.
中和処理は、最適なpHで発酵するために行われる。例えば、ナスまたはその破砕物のpHを4.0〜7.5に調節する。pHの調節は、当業者が用いる通常の方法を用いて行われる。例えば、水酸化ナトリウム、水酸化カルシウム、炭酸ナトリウム、重曹、クエン酸ナトリウムなどのpH調整剤、電解水、緩衝液(例えばクエン酸緩衝液、酢酸緩衝液、リン酸緩衝液)などを添加して、pHを調節することができる。 The neutralization treatment is performed for fermentation at an optimum pH. For example, the pH of eggplant or its crushed material is adjusted to 4.0 to 7.5. Adjustment of pH is performed using the usual method used by those skilled in the art. For example, pH adjusters such as sodium hydroxide, calcium hydroxide, sodium carbonate, sodium bicarbonate, sodium citrate, etc., electrolyzed water, buffer solution (eg citrate buffer solution, acetate buffer solution, phosphate buffer solution) etc. are added. PH can be adjusted.
上述の酵素処理および中和処理は、いずれも、発酵を促進させて比較的短時間で発酵することにより、ナスに含有される有効な成分の損失を少なくすることができる点で有用である。そして、酵素処理または中和処理したナスまたはその破砕物と、発酵能力が高い微生物(例えば後述する特定の乳酸菌等)とを組合せて、下記の発酵工程で発酵を行えば、比較的短時間(例えば、24時間〜72時間)で発酵を完了させることができる。 Both the enzyme treatment and the neutralization treatment described above are useful in that the loss of effective components contained in eggplant can be reduced by promoting fermentation in a relatively short time. And, when fermentation is performed in the following fermentation process by combining an enzyme-treated or neutralized eggplant or a crushed product thereof with a microorganism having high fermentation ability (for example, a specific lactic acid bacterium described later), a relatively short time ( For example, fermentation can be completed in 24 hours to 72 hours).
(発酵工程)
次に、発酵工程について説明する。上記ナスまたはその破砕物を発酵させることにより、または、上記酵素処理および中和処理のうちの少なくとも1種で処理したナスを発酵させることにより、本発明の発酵物を得ることができる。
(Fermentation process)
Next, the fermentation process will be described. The fermented product of the present invention can be obtained by fermenting the eggplant or its crushed material, or fermenting eggplant treated with at least one of the enzyme treatment and neutralization treatment.
発酵としては、乳酸発酵、クエン酸発酵、アルコール発酵、酢酸発酵などが挙げられる。これらの中でも、乳酸発酵が好ましく、これらの発酵を組み合わせてもよい。発酵させる時間は、例えば24時間〜72時間で終了することが好ましい。また、発酵の種類に応じては、乳酸菌、酵母菌、酢酸菌などが用いられる。酵母や酢酸菌は、耐酸性が強いため、特に好ましく用いられる。 Examples of fermentation include lactic acid fermentation, citric acid fermentation, alcohol fermentation, and acetic acid fermentation. Among these, lactic acid fermentation is preferable, and these fermentations may be combined. The fermentation time is preferably finished, for example, in 24 hours to 72 hours. Moreover, lactic acid bacteria, yeasts, acetic acid bacteria, etc. are used according to the kind of fermentation. Yeast and acetic acid bacteria are particularly preferably used because of their strong acid resistance.
(乳酸発酵)
乳酸発酵は、上記ナスまたはその破砕物を乳酸菌と接触させることによって行われる。乳酸発酵は、得られる発酵物中に乳酸が含有される点で好ましい。含有される乳酸の量については、発酵物の乾燥質量100g当り、乳酸を乾燥質量換算で0.1mg(0.0001質量%)以上、好ましくは0.5mg(0.0005質量%)以上、より好ましくは1mg(0.001質量%)以上とするのがよい。
(Lactic acid fermentation)
Lactic acid fermentation is carried out by bringing the eggplant or its crushed material into contact with lactic acid bacteria. Lactic acid fermentation is preferable in that lactic acid is contained in the obtained fermented product. Regarding the amount of lactic acid contained, per 100 g of dry mass of the fermented product, lactic acid is 0.1 mg (0.0001 mass%) or more, preferably 0.5 mg (0.0005 mass%) or more, in terms of dry mass. Preferably it is 1 mg (0.001 mass%) or more.
本発明で用いることができる乳酸菌としては、例えば、ロイコノストック属、ラクトバチルス属、ストレプトコッカス属、ビフィドバクテリウム属、ペディオコッカス属、エンテロコッカス属、およびペディオコッカス属に分類される乳酸菌が挙げられる。本発明で用いることができる乳酸菌の具体例としては、ロイコノストック・メセントロイデス(Leuconostoc mesenteroides)、ラクトバチルス・プランタラム(Lactobacillus plantarum)、ラクトバチルス・ブレビス(Lactobacillus brevis)、ラクトバチルス・デルブロイキ(Lactobacillus delbrueckii(さらに具体的にはLactobacillus delbrueckii subsp. bulgaricus))、ラクトバチルス・ガッセリ(Lactobacillus gasseri)、ラクトバチルス・アシドフィルス(Lactobacillus acidophilus)、ラクトバチルス・カゼイ(Lactobacillus casei)、ストレプトコッカス・サーモフィラス(Streptococcus thermophilus)、ストレプトコッカス・フェカリス(Streptococcus faecalis)、ビフィドバクテリウム・ロンガム(Bifidobacterium longum)、ビフィドバクテリウム・ビフィダム(Bifidobacterium bifidum)、ビフィドバクテリウム・ラクティス(Bifidobacterium lactis)、バチルス・メセンテリカス(Bacillus mesentericus)などが挙げられる。 Examples of lactic acid bacteria that can be used in the present invention include lactic acid bacteria classified into the genus Leuconostoc, Lactobacillus, Streptococcus, Bifidobacterium, Pediococcus, Enterococcus, and Pediococcus. Can be mentioned. Specific examples of lactic acid bacteria that can be used in the present invention include Leuconostoc mesenteroides, Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus brevis, Lactobacillus delvis. Lactobacillus delbrueckii (more specifically, Lactobacillus delbrueckii subsp. Bulgaricus), Lactobacillus gasseri (Lactobacillus gassili), Lactobacillus acidophilus acillus casei), Streptococcus thermophilus, Streptococcus faecalis (Bifidobacterium longum), Bifidobacterium longum (Bifidobacterium longum) lactis), Bacillus mesentericus, and the like.
本発明では、発酵させる素材としてナスを用いているので、乳成分を要求しない乳酸菌、例えば漬物などで見られる乳酸菌を用いてもよい。そのような乳酸菌の具体例としては、ラクトバチルス・プランタラム(Lactobacillus plantarum)、ロイコノストック・メセンテロイデス(Leuconostoc mesenteroides)、エンテロコッカス・フェーカリス(Enterococcus faecalis)、エンテロコッカス・フェーシウム(Enterococcus faecium)、ラクトバチルス・ブレビス(Lactobacillus brevis)、ペディオコッカス・アシディラクティシ(Pediococcus acidilactici)、ペディオコッカス・ペントサセウス(Pediococcus pentosaceus)、ペディオコッカス・ハロフィラス(Pediococcus halophilus)などが挙げられる。 In the present invention, eggplant is used as a material to be fermented, so that lactic acid bacteria that do not require milk components, for example, lactic acid bacteria found in pickles may be used. Specific examples of such lactic acid bacteria include Lactobacillus plantarum, Leuconostoc mesenteroides, Enterococcus faecalis, Enterococcus faecalis, Enterococcus faecalis, (Lactobacillus brevis), Pediococcus acidilactici, Pediococcus pentoaceaceus, Pediococcus halophyllus (Pediococcus halophilus) lus).
なお、本発明において、上記乳酸菌は、単独で用いてもよく、違う種類の乳酸菌を組み合わせて用いてもよい。 In the present invention, the lactic acid bacteria may be used alone or in combination with different types of lactic acid bacteria.
本発明において、微生物(特に乳酸菌)を用いて発酵を行えば、得られる発酵物は、酵素阻害活性を有する物となる。ここでいう酵素阻害活性としては、例えば、チロシナーゼ阻害活性、グルコシダーゼ阻害活性(例えばα−グルコシダーゼ阻害活性)などが挙げられる。よって、微生物(特に乳酸菌)を用いてナスを発酵させることは有用である。 In this invention, if fermentation is performed using microorganisms (especially lactic acid bacteria), the obtained fermented material will be a thing which has enzyme inhibitory activity. Examples of the enzyme inhibitory activity herein include tyrosinase inhibitory activity, glucosidase inhibitory activity (eg, α-glucosidase inhibitory activity), and the like. Therefore, it is useful to ferment eggplant using microorganisms (particularly lactic acid bacteria).
発酵を行うにあたり、ナスまたはその破砕物100質量部に対して、微生物(特に乳酸菌)は、乾燥菌体質量で0.005〜10質量部、好ましくは0.01〜5.0質量部添加するのがよい。 In performing the fermentation, the microorganism (particularly lactic acid bacteria) is added in an amount of 0.005 to 10 parts by mass, preferably 0.01 to 5.0 parts by mass with respect to 100 parts by mass of eggplant or its crushed material. It is good.
また、乳酸菌の優先的な生育のために、生育用の添加物を添加してもよい。ここでいう生育用の添加物としては、例えば、グルタミン酸またはその塩、酵母エキス、ペプトンなどが挙げられる。生育用の添加物の添加量は、特に限定されないが、ナスまたはその破砕物に対して0.05〜1質量%程度、好ましくは0.2質量%程度とするのがよい。 Moreover, you may add the additive for growth for the preferential growth of lactic acid bacteria. Examples of the growth additive herein include glutamic acid or a salt thereof, yeast extract, peptone, and the like. The amount of the additive for growth is not particularly limited, but it is about 0.05 to 1% by mass, preferably about 0.2% by mass with respect to eggplant or its crushed material.
また、乳酸菌の発酵を促進するために、乳酸菌代謝性の糖を添加してもよい。この糖の添加は、糖分含量が少ない植物(例えば糖分含量が1質量%未満の植物)を発酵させる場合に有用である。もちろん、発酵の促進および発酵物への甘味の付加という目的で糖を添加してもよい。糖を添加する場合、その種別は特に限定されないが、乳酸菌が生育または発酵に利用することができる糖を添加することが好ましく、例えば、庶糖、ぶどう糖、果糖、麦芽糖などを添加するのが好ましい。もちろん、ここに例示した糖とは別の糖を添加してもよい。添加する糖の量については、糖分が、ナスの糖分と合わせて約1〜6質量%になるように加えることが好ましい。 Moreover, in order to promote fermentation of lactic acid bacteria, lactic acid bacteria metabolic sugar may be added. This addition of sugar is useful when fermenting a plant having a low sugar content (for example, a plant having a sugar content of less than 1% by mass). Of course, sugar may be added for the purpose of promoting fermentation and adding sweetness to the fermented product. When sugar is added, the type is not particularly limited, but it is preferable to add sugar that can be used for growth or fermentation of lactic acid bacteria. For example, sucrose, glucose, fructose, maltose and the like are preferably added. Of course, sugars other than the sugars exemplified here may be added. About the quantity of the sugar to add, it is preferable to add so that sugar content may become about 1-6 mass% in total with the sugar content of eggplant.
乳酸発酵は、乳酸菌が優先的に増殖できる環境をつくるため、ナスまたはその破砕物のpHを予め中和処理により調節しておくことが好ましい。例えば、ラクトバチルス・プランタラムを用いる場合は、pHを4.0程度に調節した後に発酵を開始すれば、短期間でその発酵を終了させることができる。 In lactic acid fermentation, in order to create an environment in which lactic acid bacteria can preferentially grow, it is preferable to adjust the pH of eggplant or its crushed material in advance by neutralization. For example, in the case of using Lactobacillus plantarum, if the fermentation is started after adjusting the pH to about 4.0, the fermentation can be completed in a short period of time.
乳酸発酵は、アスコルビン酸の分解を抑制する観点から、嫌気性条件下で行うことが好ましい。嫌気性条件は、例えば、ナスまたはその破砕物を発酵槽に入れた後、脱気することにより、または発酵槽を密封するか、窒素、二酸化炭素などのガスで満たすか、減圧することにより、あるいはそれらを組み合わせることにより得られる。また、嫌気条件下で発酵を行うことにより、得られる発酵物の風味も良くなる。 Lactic acid fermentation is preferably performed under anaerobic conditions from the viewpoint of suppressing the decomposition of ascorbic acid. Anaerobic conditions are, for example, by putting eggplant or crushed material thereof into a fermenter and then degassing, or by sealing the fermenter, filling with a gas such as nitrogen or carbon dioxide, or reducing the pressure. Or it is obtained by combining them. Moreover, the flavor of the fermented material obtained by performing fermentation under anaerobic conditions also becomes good.
乳酸発酵の条件に特に制限はない。発酵温度は、通常、4℃〜50℃で行われ得る。発酵時間は、発酵温度に応じて適宜設定すればよく、20℃〜50℃で発酵を行う場合、12時間〜72時間、好ましくは24時間〜72時間である。さらに、風味を高める目的で4℃〜10℃の低温発酵を行う場合は、アスコルビン酸などのナスに含有される成分の損失を考慮すると、5日間〜14日間が好ましい。 There are no particular restrictions on the conditions for lactic acid fermentation. Fermentation temperature can be normally performed at 4 to 50 degreeC. What is necessary is just to set fermentation time suitably according to fermentation temperature, and when performing fermentation at 20 to 50 degreeC, they are 12 hours-72 hours, Preferably they are 24 hours-72 hours. Furthermore, when performing low-temperature fermentation at 4 ° C. to 10 ° C. for the purpose of enhancing the flavor, 5 to 14 days are preferable in consideration of loss of components contained in eggplant such as ascorbic acid.
乳酸発酵は、糖を加えて発酵を停止させることができる。このような糖としては、糖アルコール(例えば、ソルビトール)、オリゴ糖(例えば、マルトオリゴ糖、キトオリゴ糖、フラクトオリゴ糖)などが挙げられる。このようなオリゴ糖は、整腸作用、う蝕の予防などに効果があり、得られる発酵物に機能性を付与し得る。 Lactic acid fermentation can be stopped by adding sugar. Examples of such sugars include sugar alcohols (for example, sorbitol), oligosaccharides (for example, maltooligosaccharide, chitooligosaccharide, fructooligosaccharide) and the like. Such oligosaccharides are effective for intestinal regulation, prevention of dental caries, and the like, and can impart functionality to the obtained fermented product.
乳酸発酵は、ナス中の成分を資化して有機酸やオリゴ糖などの有用成分を産生するだけでなく、発酵物を低いpHに維持できるため、他の雑菌の繁殖を防ぐことも可能である。また、乳酸菌を添加するため、風味の改善や整腸作用、酵素阻害作用などの生理活性の高いナス発酵物を得ることができる。 Lactic acid fermentation not only assimilates the components in eggplant to produce useful components such as organic acids and oligosaccharides, but also maintains the fermented product at a low pH, so it is possible to prevent the propagation of other germs . Moreover, since lactic acid bacteria are added, a fermented eggplant product with high physiological activities such as flavor improvement, intestinal regulation and enzyme inhibition can be obtained.
(クエン酸発酵)
クエン酸発酵は、一般的には、酵母を、ナスまたはその破砕物と好気的条件下で接触させて培養することによって行われる。クエン酸発酵において、乳酸菌をさらに添加して発酵すると、酵母の増殖が促進されやすく、さらに得られる発酵物の嗜好性も高まるため好ましい。
(Citric acid fermentation)
Citric acid fermentation is generally performed by culturing yeast in contact with eggplant or a crushed product thereof under aerobic conditions. In citric acid fermentation, it is preferable to add lactic acid bacteria and ferment, because the growth of yeast is easily promoted and the preference of the obtained fermented product is also increased.
酵母としては、清酒酵母、ワイン酵母、ビール酵母、パン酵母などが用いられる。例えば、サッカロミセス属、シゾサッカロミセス属などに属する酵母が用いられ、好ましくは、サッカロミセス・セレビシエ、サッカロミセス・パストリアヌス、シゾサッカロミセス・ポンベなどが挙げられる。特にアミノ酸やビタミンなどの有用物質を産生する点で、サッカロミセス・セレビシエおよびその単離株が好ましい。 As yeast, sake yeast, wine yeast, beer yeast, baker's yeast and the like are used. For example, yeast belonging to the genus Saccharomyces, Schizosaccharomyces, etc. is used, and preferred examples include Saccharomyces cerevisiae, Saccharomyces pastorianus, Schizosaccharomyces pombe and the like. In particular, Saccharomyces cerevisiae and its isolates are preferred in terms of producing useful substances such as amino acids and vitamins.
酵母は、ナスまたはその破砕物100質量部に対して、乾燥体質量で0.001〜15質量部、好ましくは0.01〜10質量部添加する。 Yeast is added in an amount of 0.001 to 15 parts by mass, preferably 0.01 to 10 parts by mass with respect to 100 parts by mass of eggplant or its crushed material.
クエン酸発酵は、ナスまたはその破砕物と酵母とを発酵槽に入れ、通気攪拌しながら、4℃〜40℃、好ましくは10℃〜35℃で24時間〜14日間行う。特にナスが酸性であると酵母発酵により香気成分が高くなるため、より嗜好性の高い発酵物を得ることができる。 Citric acid fermentation is carried out at 4 ° C. to 40 ° C., preferably 10 ° C. to 35 ° C. for 24 hours to 14 days, with eggplant or its crushed material and yeast placed in a fermenter and aerated and stirred. In particular, when eggplant is acidic, aroma components are increased by yeast fermentation, so that a fermented product with higher palatability can be obtained.
クエン酸発酵は、酵母を用いて行われるため、発酵物中に酵母が産生するアミノ酸、タンパク質、ビタミン類などが含まれ、栄養価が高く嗜好性に優れる点で好ましい。 Since citric acid fermentation is performed using yeast, amino acids, proteins, vitamins and the like produced by yeast are contained in the fermented product, which is preferable in terms of high nutritional value and excellent palatability.
(アルコール発酵および酢酸発酵)
アルコール発酵は、酵母を、ナスまたはその破砕物と嫌気条件下で接触させて培養することによって行われる。アルコール発酵に用いられる酵母の種類および量は、上記クエン酸発酵の場合と同様である。発酵条件も、嫌気条件にすること以外は、上記クエン酸発酵の場合と同様である。こうしてアルコール発酵で得られたナス発酵物は、さらに以下で述べる酢酸発酵に供することが好ましい。
(Alcohol fermentation and acetic acid fermentation)
Alcohol fermentation is performed by culturing yeast in contact with eggplant or a crushed product thereof under anaerobic conditions. The kind and amount of yeast used for alcoholic fermentation are the same as in the case of the citric acid fermentation. The fermentation conditions are the same as in the above citric acid fermentation except that the conditions are anaerobic. The eggplant fermented product thus obtained by alcohol fermentation is preferably subjected to acetic acid fermentation described below.
酢酸発酵は、ナスまたはその破砕物にアルコールを加え、所定のアルコール濃度にした後、酢酸発酵し得る微生物(酢酸菌)を添加することによって行われる。酢酸発酵は、一般的には、微生物(酢酸菌)を、ナスまたはその破砕物と好気的条件下で接触させて培養することによって行われる。あるいは上記のアルコール発酵によって得られたナス発酵物に酢酸菌を添加して二段発酵させてもよい。 Acetic acid fermentation is performed by adding alcohol to eggplant or a crushed product thereof to obtain a predetermined alcohol concentration, and then adding a microorganism (acetic acid bacterium) capable of acetic acid fermentation. In general, acetic acid fermentation is performed by culturing a microorganism (acetic acid bacterium) in contact with eggplant or a crushed product thereof under aerobic conditions. Alternatively, acetic acid bacteria may be added to the fermented eggplant obtained by the above alcohol fermentation to cause two-stage fermentation.
アルコール濃度は、酢酸菌が生育できる濃度であれば、特に制限されず、発酵時間などに応じて適宜調整すればよい。好ましくは10質量/容量%以下、より好ましくは1〜6質量/容量%である。 The alcohol concentration is not particularly limited as long as it is a concentration at which acetic acid bacteria can grow, and may be appropriately adjusted according to fermentation time and the like. Preferably it is 10 mass / volume% or less, More preferably, it is 1-6 mass / volume%.
酢酸菌としては、アセトバクター属に属する微生物、例えば、アセトバクター・アセチ、アセトバクター・パステウリアヌス、アセトバクター・ハンセニなどが挙げられる。 Examples of the acetic acid bacteria include microorganisms belonging to the genus Acetobacter, such as Acetobacter aceti, Acetobacter pasteurianus, Acetobacter hanseni, and the like.
酢酸菌は、適切な培地で15℃〜40℃、好ましくは25℃〜35℃にて6〜48時間予備培養しておくことが好ましい。予備培養した酢酸菌は、例えば、次のようにして得られる。まず、ポテト200g、破砕酵母30g、肝臓エキス25g、肉エキス5g、チオグリコール酸培地10g、グルコース5g、グリセロール15g、および炭酸カルシウム15gを含有する1Lの酢酸菌培地(pH7.0)に酢酸菌を添加して、15℃〜40℃にて24時間予備培養する。次いで、得られた培養物を遠心分離し、回収した菌体を滅菌水で洗浄し、再度遠心分離して上清を除去することによって、予備培養した酢酸菌が得られる。 The acetic acid bacteria are preferably precultured in an appropriate medium at 15 to 40 ° C, preferably 25 to 35 ° C for 6 to 48 hours. The pre-cultured acetic acid bacteria can be obtained, for example, as follows. First, acetic acid bacteria were added to 1 L of acetic acid bacteria medium (pH 7.0) containing 200 g of potato, 30 g of crushed yeast, 5 g of liver extract, 5 g of meat extract, 10 g of thioglycolic acid medium, 5 g of glucose, 15 g of glycerol, and 15 g of calcium carbonate. Add and pre-incubate at 15-40 ° C. for 24 hours. Next, the obtained culture is centrifuged, and the collected cells are washed with sterilized water, and centrifuged again to remove the supernatant, thereby obtaining pre-cultured acetic acid bacteria.
酢酸発酵は、攪拌培養、振盪培養、および静置培養のいずれでも行うことができる。発酵温度は10℃〜40℃、好ましくは20℃〜35℃で行われる。発酵時間は、酢酸菌の添加量に応じて適宜設定され、通常、1日〜1週間が好適である。 Acetic acid fermentation can be performed by any of stirring culture, shaking culture, and stationary culture. The fermentation temperature is 10 ° C to 40 ° C, preferably 20 ° C to 35 ° C. Fermentation time is suitably set according to the addition amount of acetic acid bacteria, and usually 1 day to 1 week is suitable.
上記発酵後は、さらに必要に応じて、殺菌または除菌してもよい。例えば、加圧式殺菌、熱交換式殺菌、蒸煮殺菌、限外ろ過などの当業者が通常用いる方法が用いられる。加熱殺菌の場合、例えば、60℃〜120℃にて5秒間〜12時間行われる。 After the fermentation, it may be further sterilized or sterilized as necessary. For example, methods commonly used by those skilled in the art such as pressure sterilization, heat exchange sterilization, steam sterilization, and ultrafiltration are used. In the case of heat sterilization, for example, it is performed at 60 ° C. to 120 ° C. for 5 seconds to 12 hours.
(発酵物)
このようにナスを発酵して得られる発酵物(ナス発酵物)は、そのまま使用してもよいし、必要に応じて、その後当業者が通常用いる処理方法によって種々の態様で使用してもよい。このような態様としては、例えば、上記のように発酵物を固液分離して上清を回収することにより得られた発酵エキス、該発酵物または該発酵エキスを濃縮処理した発酵ペースト、該発酵物または該発酵エキスを乾燥・粉末化処理した発酵粉末または発酵エキス末などが挙げられる。これらは、すべてナス発酵物の一態様である。
(Fermented product)
The fermented material obtained by fermenting eggplant in this manner (fermented eggplant product) may be used as it is, or may be used in various embodiments depending on the processing method usually used by those skilled in the art, if necessary. . Examples of such an embodiment include a fermented extract obtained by solid-liquid separation of a fermented product as described above and collecting the supernatant, a fermented paste obtained by concentrating the fermented product or the fermented extract, and the fermentation Or a fermented powder or fermented extract powder obtained by drying / pulverizing the product or the fermented extract. These are all aspects of fermented eggplant.
上記ナス発酵物の実施態様の1つに、発酵粉末または発酵エキス末がある。それら発酵粉末または発酵エキス末は、具体的には、該発酵物または発酵エキスを、乾燥、粉末化することによって得られる。乾燥は、当業者が通常用いる種々の方法により行えばよいが、凍結乾燥、噴霧乾燥が好ましく用いられる。噴霧乾燥は、必要に応じて、デキストリン、シクロデキストリン、デンプン、マルトースなどの賦形剤を添加して行われる。発酵物または発酵エキスと賦形剤との混合比は、発酵物を乾燥する場合、好ましくは質量比で1:5〜10:1、発酵エキスを乾燥する場合、好ましくは質量比1:10〜5:1である。上記混合比で乾燥することにより得られる発酵粉末または発酵エキス末の褐変を防ぐことができる。 One embodiment of the above fermented eggplant is a fermented powder or fermented extract powder. Specifically, these fermented powder or fermented extract powder can be obtained by drying and pulverizing the fermented product or fermented extract. Drying may be performed by various methods commonly used by those skilled in the art, but freeze drying and spray drying are preferably used. Spray drying is performed by adding excipients such as dextrin, cyclodextrin, starch, and maltose as necessary. When the fermented product is dried, the mixing ratio of the fermented product or fermented extract and the excipient is preferably 1: 5 to 10: 1 by mass ratio, and when the fermented extract is dried, the mass ratio is preferably 1:10 to 10: 1. 5: 1. Browning of the fermented powder or fermented extract powder obtained by drying at the above mixing ratio can be prevented.
本発明の発酵物は、香りおよび風味がよく嗜好性に優れている。そして、発酵によって、ナスが本来有しない新規な機能(活性)を付与する、または、ナスが本来有する生理活性を増強することができる。つまり、発酵前と比べて、発酵後の方が、高い生理活性を有する発酵物を製造することができる。ここでいう新規な機能(活性)および生理活性としては、例えば酵素阻害活性などが挙げられる。 The fermented product of the present invention has a good fragrance and flavor and is excellent in palatability. And by fermentation, the novel function (activity) which eggplant originally does not have can be provided, or the physiological activity which eggplant originally has can be reinforced. That is, a fermented product having higher physiological activity can be produced after fermentation than before fermentation. Examples of the novel function (activity) and physiological activity here include enzyme inhibition activity.
ナスが本来有している生理活性であって増強される生理活性の具体例としては、チロシナーゼ阻害活性やグルコシダーゼ阻害活性(α−グルコシダーゼ阻害活性)が挙げられる。このような活性を有するナス発酵物は、様々な機能性食品や医薬品原料として使用することができる。 Specific examples of the physiological activity that eggplant originally has and are enhanced include tyrosinase inhibitory activity and glucosidase inhibitory activity (α-glucosidase inhibitory activity). The fermented eggplant having such activity can be used as various functional foods and pharmaceutical raw materials.
本発明のナス発酵物は、上述のように、チロシナーゼ阻害活性やα−グルコシダーゼ阻害活性といった様々な生理活性を有するため、さまざまな作用および効果が期待できる。例えば、チロシナーゼ阻害活性によれば、肌の美白効果、クスミの改善等の効果が期待できる。α−グルコシダーゼ阻害活性によれば、糖の消化吸収抑制効果、血糖値上昇抑制効果、糖尿病および糖尿病合併予防効果、抗肥満効果が期待できる。 Since the eggplant fermented product of the present invention has various physiological activities such as tyrosinase inhibitory activity and α-glucosidase inhibitory activity as described above, various actions and effects can be expected. For example, according to the tyrosinase inhibitory activity, effects such as skin whitening effect and improvement of the skin can be expected. According to the α-glucosidase inhibitory activity, an effect of inhibiting digestion and absorption of sugar, an effect of suppressing an increase in blood glucose level, an effect of preventing diabetes and diabetic complications, and an anti-obesity effect can be expected.
(経口用組成物および経皮用組成物)
本発明のナス発酵物は、上記のような活性を有する。そのため、本発明のナス発酵物を含有させて経皮用組成物または経口用組成物として利用することは、きわめて有用である。
(Oral composition and transdermal composition)
The fermented eggplant of the present invention has the above activity. Therefore, it is very useful to contain the eggplant fermented product of the present invention and use it as a transdermal composition or oral composition.
本発明の経皮用組成物および経口用組成物は、上記発酵物を含有している。もちろん、必要に応じて、その他の成分を含有することができる。なお、ここでいう経口用組成物には、食品をはじめ、経口投与を目的とした医薬品、医薬部外品等が包含される。また、ここでいう経皮用組成物には、化粧品をはじめ、経皮投与を目的とした医薬品、医薬部外品等、トイレタリー用品などが包含される。 The transdermal composition and oral composition of the present invention contain the fermented product. Of course, other components can be contained as required. The oral composition mentioned here includes foods, pharmaceuticals intended for oral administration, quasi drugs and the like. Further, the transdermal composition referred to here includes cosmetics, pharmaceuticals intended for transdermal administration, quasi-drugs, toiletries and the like.
本発明の組成物中において、発酵物の含有量は特に制限されない。しかし、ナス発酵物が有する生理作用を得ることを考慮すれば、次のような量とするのがよい。例えば、経口用組成物とする場合(食品など経口投与を目的とする場合)、発酵物の含有量の下限値は、0.001質量%以上、好ましくは0.01質量%以上とするのがよく、発酵物の含有量の上限値は、100%以下、好ましくは70%以下とするのがよい。経皮用組成物とする場合(化粧品などの経皮投与を目的とする場合)、発酵物の含有量の下限値は、0.00001質量%以上、好ましくは0.0001質量%以上とするのがよく、発酵物の含有量の上限値は、50質量%以下、好ましくは30質量%以下とするのがよい。 In the composition of the present invention, the content of the fermented product is not particularly limited. However, in consideration of obtaining the physiological effects of the fermented eggplant, the following amounts are preferable. For example, when it is set as an oral composition (when aiming at oral administration, such as food), the lower limit of content of fermented material is 0.001 mass% or more, Preferably it is 0.01 mass% or more. The upper limit of the content of the fermented product is 100% or less, preferably 70% or less. In the case of a transdermal composition (for the purpose of transdermal administration such as cosmetics), the lower limit of the fermented product content is 0.00001% by mass or more, preferably 0.0001% by mass or more. The upper limit of the content of the fermented product is 50% by mass or less, preferably 30% by mass or less.
本発明の組成物は、上述のように、必要に応じて、種々の成分を含有し得る。種々の成分の含有量は、用途等を考慮して任意に決定すればよい。ここでいう種々の成分としては、例えば、通常の食品として添加し得る成分、具体的には、賦形剤、増量剤、結合剤、増粘剤(例えば寒天)、乳化剤、滑沢剤、湿潤剤、懸濁剤、着色料(色素)、食品添加物、調味料など、または、医薬部外品、化粧品、およびトイレタリー用品として添加し得る成分(基材、動植物抽出物など)が挙げられる。もちろん、これら種々の成分は、単独で含有させてもよく、組み合わせて含有させてもよい。 As described above, the composition of the present invention may contain various components as necessary. What is necessary is just to determine content of a various component arbitrarily in consideration of a use etc. Examples of the various components mentioned here include components that can be added as ordinary foods, specifically excipients, extenders, binders, thickeners (for example, agar), emulsifiers, lubricants, and wets. Ingredients (base materials, animal and plant extracts, etc.) that can be added as agents, suspensions, colorants (pigments), food additives, seasonings, etc., or quasi-drugs, cosmetics, and toiletries. Of course, these various components may be contained alone or in combination.
上記種々の成分の具体例としては、ローヤルゼリー、プロポリス、ビタミン類(A、B群、C、D、E、K、葉酸、パントテン酸、ビオチン、これらの誘導体等)ミネラル(鉄、マグネシウム、カルシウム、亜鉛等)、セレン、キチン・キトサン、レシチン、ポリフェノール(カテキン類、アントシアニン類、プロアントシアニジンなどの縮合型タンニン、ガロタンニン等の加水分解型タンニン、フラボノイド類、これらの誘導体等)、カロテノイド(リコピン、アスタキサンチン、ゼアキサンチン、ルテイン等)、サポニン(イソフラボン、ジンセサノイド、グリチルリチン酸等)、キサンチン誘導体(カフェイン等)、脂肪酸、アミノ酸、タンパク質(コラーゲン、エラスチン等)、ムコ多糖類(ヒアルロン酸、コンドロイチン、デルマタン、ヘパラン、ヘパリン、ケタラン、これらの塩等)、アミノ糖(グルコサミン、アセチルグルコサミン、ガラクトサミン、アセチルガラクトサミン、ノイラミン酸、アセチルノイラミン酸、ヘキソサミン、それらの塩等)、食物繊維(難消化性デキストリン、アルギン酸、グアガム、ペクチン、グルコマンナン等)、オリゴ糖(イソマルトオリゴ糖、環状オリゴ糖等)リン脂質及びその誘導体(フォスファチジルコリン、スフィンゴミエリン、セラミド等)、含硫化合物(アリイン、セパエン、タウリン、グルタチオン、メチルスルホニルメタン等)、糖アルコール、キノン類(コエンザイムQ10等)、リグナン類(セサミン等)、これらを含有する動植物抽出物、根菜類(ウコン、ショウガ等)、麦若葉末等のイネ科植物の緑葉、ケール等のアブラナ科植物の緑葉などが挙げられる。さらに、これら食品添加物を含む飲料、例えば、植物発酵ジュース、野菜ジュース(例えば、人参ジュース)、植物抽出物、果汁などを上記種々の成分として利用してもよく、これらを含有させることにより、機能性または栄養価の高い飲料を得ることができる。 Specific examples of the various components include royal jelly, propolis, vitamins (A, B group, C, D, E, K, folic acid, pantothenic acid, biotin, derivatives thereof, etc.) minerals (iron, magnesium, calcium, Zinc, etc.), selenium, chitin / chitosan, lecithin, polyphenol (condensed tannins such as catechins, anthocyanins, proanthocyanidins, hydrolyzed tannins such as gallotannins, flavonoids, derivatives thereof, etc.), carotenoids (lycopene, astaxanthin) Zeaxanthin, lutein, etc.), saponins (isoflavones, ginsaneoids, glycyrrhizic acid, etc.), xanthine derivatives (caffeine, etc.), fatty acids, amino acids, proteins (collagen, elastin, etc.), mucopolysaccharides (hyaluronic acid, chondroitin, derma) , Heparan, heparin, ketalan, and their salts), amino sugars (glucosamine, acetylglucosamine, galactosamine, acetylgalactosamine, neuraminic acid, acetylneuraminic acid, hexosamine, their salts, etc.), dietary fiber (indigestible dextrin) , Alginic acid, guar gum, pectin, glucomannan, etc.), oligosaccharides (isomalto-oligosaccharides, cyclic oligosaccharides, etc.), phospholipids and derivatives thereof (phosphatidylcholine, sphingomyelin, ceramide, etc.), sulfur-containing compounds (allyin, sepaene, Taurine, glutathione, methylsulfonylmethane, etc.), sugar alcohols, quinones (coenzyme Q10, etc.), lignans (sesamin, etc.), animal and plant extracts containing these, root vegetables (turmeric, ginger, etc.), wheat leaves, etc. Green leaves of grass family, ke Such as the green leaves of cruciferous plants such as Le and the like. Furthermore, beverages containing these food additives, for example, plant fermented juice, vegetable juice (for example, carrot juice), plant extract, fruit juice, etc. may be used as the above various components, and by containing these, Beverages with high functionality or nutritional value can be obtained.
もちろん、上記種々の成分として、調味料を添加してもよい。ここでいう調味料の具体例としては、グラニュー糖、蜂蜜、ソルビットなどの甘味料、アルコール、クエン酸、リンゴ酸、酒石酸などの酸味料、および香料などが挙げられる。 Of course, you may add a seasoning as said various components. Specific examples of the seasoning herein include sweeteners such as granulated sugar, honey and sorbit, acidulants such as alcohol, citric acid, malic acid and tartaric acid, and flavors.
本発明の組成物は、目的に応じて、各種の形態に調製して利用することができる。例えば、食品などの経口用組成物として利用する場合は、ハードカプセル、ソフトカプセルなどのカプセル剤、錠剤、丸剤、粉末(散剤)、顆粒、ティーバッグ、液体(飲料)、ペーストなどの当業者が通常用いる形態とすることができる。さらに、上記液体などを加工して、ゼリー、シャーベット、フローズンヨーグルトあるいはアイスクリームとすることもできる。これらは、形状または好みに応じて、そのまま摂取してもよく、あるいは水、湯、牛乳などに溶いて、または成分を浸出して飲むことができる。なお、飲料の場合、低pHであれば、120℃、4分の完全殺菌をしなくても、100℃以下の殺菌条件で殺菌できる。例えば、pHが4.0以下の場合では、65℃、10分相当の殺菌条件で十分に殺菌できる。経皮用組成物(医薬部外品、化粧品、トイレタリー用品など)として利用する場合は、例えば、化粧水、化粧クリーム、乳液、パック、ヘアトニック、シャンプー、ヘアリンス、トリートメント、ボディーシャンプー、先顔剤、石鹸、ファンデーション、口紅、育毛剤、軟膏、入浴剤、歯磨剤、マウスウウォッシュ、シップ、ゲルなどの形態とすることができる。 The composition of the present invention can be prepared and used in various forms according to the purpose. For example, when used as an oral composition for foods, etc., those skilled in the art usually use capsules such as hard capsules and soft capsules, tablets, pills, powders (powder), granules, tea bags, liquids (beverages), pastes, etc. It can be set as the form used. Furthermore, the liquid etc. can be processed into jelly, sorbet, frozen yogurt or ice cream. These may be taken as they are, depending on the shape or preference, or can be taken by dissolving in water, hot water, milk, etc. or leaching the ingredients. In the case of beverages, if the pH is low, it can be sterilized under sterilization conditions of 100 ° C. or lower without complete sterilization at 120 ° C. for 4 minutes. For example, when the pH is 4.0 or less, it can be sufficiently sterilized under sterilization conditions corresponding to 65 ° C. and 10 minutes. When used as a transdermal composition (quasi-drugs, cosmetics, toiletries, etc.), for example, lotion, cosmetic cream, emulsion, pack, hair tonic, shampoo, hair rinse, treatment, body shampoo, facial preparation , Soap, foundation, lipstick, hair restorer, ointment, bathing agent, dentifrice, mouthwash, ship, gel and the like.
以下に、実施例を挙げて本発明を説明する。なお、本発明は、下記実施例により制限されない。 Hereinafter, the present invention will be described with reference to examples. In addition, this invention is not restrict | limited by the following Example.
(実施例1:発酵物の調製)
まず、食用のナスをフードプロセッサで破砕した。次に、得られた破砕物(1質量部)にイオン交換水(2質量部)を加えて攪拌することにより、ナス希釈液を調製した。
(Example 1: Preparation of fermented product)
First, edible eggplant was crushed with a food processor. Next, eggplant dilution liquid was prepared by adding ion-exchange water (2 mass parts) to the obtained crushed material (1 mass part) and stirring.
次に、ナス希釈液に乳酸菌等を添加した。具体的には、固液分離しないナス希釈液(80g)に、乳酸菌(80mg)とグルコース(5質量/容量%)とを添加した。そして、三角フラスコ(200mL)にシリコン栓を施し、嫌気的条件下で、軽く振とうしながら、35℃にて24時間発酵させた。発酵後、得られたナスの発酵物を濾過して、発酵液を得た。 Next, lactic acid bacteria and the like were added to the diluted eggplant solution. Specifically, lactic acid bacteria (80 mg) and glucose (5 mass / volume%) were added to a diluted eggplant diluted solution (80 g) that was not subjected to solid-liquid separation. The Erlenmeyer flask (200 mL) was then sealed with a silicon stopper, and fermented at 35 ° C. for 24 hours with light shaking under anaerobic conditions. After fermentation, the obtained eggplant fermented product was filtered to obtain a fermentation broth.
発酵に用いた乳酸菌は、(1)ラクトバチルス・プランタラムのヴィニフローラ株(クリスチャンハンセン社製)、(2)ラクトバチルス・カゼイ(クリスチャンハンセン社製)、(3)ビフィドバクテリウム・ロンガム(クリスチャンハンセン社製)、(4)バチルス・メセンテリカス(東亜薬品工業社製)の4種類である。 The lactic acid bacteria used for the fermentation were (1) Lactobacillus plantarum Viniflora strain (Christian Hansen), (2) Lactobacillus casei (Christian Hansen), (3) Bifidobacterium longum ( (4) Bacillus mecentericus (manufactured by Toa Pharmaceutical Co., Ltd.).
なお、発酵を行うにあたっては、1Nの水酸化ナトリウム(NaOH)を用いた中和滴定法により、発酵前後の酸度を測定した。その酸度の測定において、発酵後の酸度は、上記発酵液を用いて測定した。発酵前の酸度は、ナス希釈液に乳酸菌を添加して得られた物をすぐに濾過し、その濾過により得られた濾液を用いて測定した。その結果を表1に示す。 In addition, when performing fermentation, the acidity before and behind fermentation was measured by the neutralization titration method using 1N sodium hydroxide (NaOH). In the measurement of the acidity, the acidity after fermentation was measured using the fermentation broth. The acidity before fermentation was measured by immediately filtering a product obtained by adding lactic acid bacteria to a diluted eggplant and using the filtrate obtained by the filtration. The results are shown in Table 1.
表1より、ラクトバチルス・プランタラムのヴィニフローラ株、ラクトバチルス・カゼイ、ビフィドバクテリウム・ロンガム、およびバチルス・メセンテリカスといった乳酸菌をナスに添加後24時間で、酸度の上昇が見られた。これは、上記4種の乳酸菌のうち、どの乳酸菌を用いても、ナスを発酵させることができることを示している。 From Table 1, an increase in acidity was observed 24 hours after adding lactic acid bacteria such as Lactobacillus plantarum Viniflora strain, Lactobacillus casei, Bifidobacterium longum, and Bacillus mecentericus to eggplant. This shows that eggplant can be fermented by using any of the above four types of lactic acid bacteria.
なお、上記発酵液を95℃にて8秒間殺菌した後に、これを凍結乾燥した。この凍結乾燥により、それぞれの乳酸菌で発酵したナス発酵液の各種乾燥粉末(ナス発酵エキス末)を得ることができた。 The fermentation broth was sterilized at 95 ° C. for 8 seconds, and then freeze-dried. By this freeze-drying, various dry powders (eggplant fermented extract powder) of eggplant fermentation liquid fermented with each lactic acid bacterium could be obtained.
(実施例2:チロシナーゼ阻害活性)
以下の方法にて、チロシナーゼ阻害活性(阻害率)を測定した。
(Example 2: Tyrosinase inhibitory activity)
Tyrosinase inhibitory activity (inhibition rate) was measured by the following method.
まず、実施例1に記載の発酵液(100μL)と、チロシナーゼ溶液(100μL、112unit/mL)とを混合して、37℃で10分間保持した。なお、ここで用いたチロシナーゼ溶液は、フナコシ社製のチロシナーゼ(800unit/mg)を、リン酸緩衝液(1/15M、pH7.0)に溶解させて調製した溶液である。 First, the fermentation broth (100 μL) described in Example 1 and a tyrosinase solution (100 μL, 112 units / mL) were mixed and held at 37 ° C. for 10 minutes. The tyrosinase solution used here is a solution prepared by dissolving tyrosinase (800 units / mg) manufactured by Funakoshi in a phosphate buffer solution (1/15 M, pH 7.0).
その後、0.03質量/容量%のDOPA溶液(100μL)を加えて、さらに37℃にて5分間保持して、試験液を得た。そして、その試験液の吸光度(475nm)を測定した。この測定で得られた結果を、測定値Aとする。なお、0.03質量/容量%のDOPA溶液は、L−DOPA(和光純薬工業社製)を、リン酸緩衝液(1/15M、pH7.0)に溶解させて調製した。 Then, 0.03 mass / volume% DOPA solution (100 μL) was added, and the mixture was further maintained at 37 ° C. for 5 minutes to obtain a test solution. Then, the absorbance (475 nm) of the test solution was measured. The result obtained by this measurement is defined as a measurement value A. In addition, the 0.03 mass / volume% DOPA solution was prepared by dissolving L-DOPA (manufactured by Wako Pure Chemical Industries, Ltd.) in a phosphate buffer solution (1/15 M, pH 7.0).
対照としては、次に示す測定値B〜Dの値を用いた。 As controls, the following measured values B to D were used.
測定値Bは、発酵液を添加しないときの値である。具体的には、実施例1に記載の発酵液の代わりにリン酸緩衝液(1/15M、pH7.0)を用いたこと以外は、測定値Aを得るための方法と同様の方法にて、測定値Bを取得した。 The measured value B is a value when no fermentation broth is added. Specifically, in the same manner as the method for obtaining the measurement value A except that a phosphate buffer (1/15 M, pH 7.0) was used instead of the fermentation broth described in Example 1. The measured value B was obtained.
測定値Cは、測定値Aのブランクである。具体的には、チロシナーゼ溶液の代わりにリン酸緩衝液(1/15M、pH7.0)を用いたこと以外は、測定値Aを得るための方法と同様の方法にて、測定値Cを取得した。 The measurement value C is a blank of the measurement value A. Specifically, the measurement value C is obtained by the same method as the method for obtaining the measurement value A except that a phosphate buffer (1/15 M, pH 7.0) is used instead of the tyrosinase solution. did.
測定値Dは、測定値Bのブランクである。具体的には、チロシナーゼ溶液の代わりにリン酸緩衝液(1/15M、pH7.0)を用いたこと以外は、測定値Bを得るための方法と同様の方法にて、測定値Dを取得した。 The measurement value D is a blank of the measurement value B. Specifically, the measurement value D is obtained by the same method as the method for obtaining the measurement value B except that a phosphate buffer (1/15 M, pH 7.0) is used instead of the tyrosinase solution. did.
各乳酸菌別および発酵前後における測定値A〜Dの値と、下記式(I)とを用いて、チロシナーゼ阻害率(%)を算出した。結果は、下記実施例4における表2に示す。なお、本測定は、三重測定(1群あたりn=3)によるものである。 The tyrosinase inhibition rate (%) was calculated using the measured values A to D before and after fermentation for each lactic acid bacterium and the following formula (I). The results are shown in Table 2 in Example 4 below. This measurement is based on a triple measurement (n = 3 per group).
なお、発酵前のチロシナーゼ阻害率については、上記実施例1に記載の発酵液の代わりに、発酵前の破砕物を濾過して得られた発酵前溶液を用いた以外は、上記と同様の方法で算出した。 In addition, about the tyrosinase inhibition rate before fermentation, it replaced with the fermentation liquid of the said Example 1, The method similar to the above except having used the solution before fermentation obtained by filtering the crushed material before fermentation. Calculated with
(実施例3:α−グルコシダーゼ阻害活性)
以下の方法にて、α−グルコシダーゼ阻害活性(阻害率)を測定した。
(Example 3: α-glucosidase inhibitory activity)
Α-glucosidase inhibitory activity (inhibition rate) was measured by the following method.
まず、実施例1に記載の発酵液(80μL)と、基質水溶液(p−ニトロフェニル−α−D−グルコピラノシド、0.02M、40μL)とを混合して、37℃で5分間保持した。次に、α−グルコシダーゼ溶液(0.04μg/mL、40μL)を加えて、さらに37℃にて15分間保持した。 First, the fermentation broth (80 μL) described in Example 1 and a substrate aqueous solution (p-nitrophenyl-α-D-glucopyranoside, 0.02 M, 40 μL) were mixed and held at 37 ° C. for 5 minutes. Next, an α-glucosidase solution (0.04 μg / mL, 40 μL) was added, and the mixture was further maintained at 37 ° C. for 15 minutes.
次に、炭酸ナトリウム水溶液(0.2M、160μL)を加えて、試験液を得た。そして、その試験液の吸光度(400nm)を測定した。この測定で得られた結果を、測定値Aとする。 Next, an aqueous sodium carbonate solution (0.2 M, 160 μL) was added to obtain a test solution. And the light absorbency (400 nm) of the test liquid was measured. The result obtained by this measurement is defined as a measurement value A.
なお、上記α−グルコシダーゼ溶液(0.04μg/mL)は、次のように調製した。まず、リン酸緩衝液(1/15M、pH7.0)に牛血清アルブミンを溶解させて、0.2%の牛血清アルブミン溶液を得る。次に、α−グルコシダーゼ(和光純薬工業社製)とリン酸緩衝液(1/15M、pH7.0)とを用いて0.1mg/mL溶液を調製し、その溶液を上記牛血清アルブミン溶液で2500倍希釈して、α−グルコシダーゼ溶液(0.04μg/mL)を得た。 The α-glucosidase solution (0.04 μg / mL) was prepared as follows. First, bovine serum albumin is dissolved in a phosphate buffer (1/15 M, pH 7.0) to obtain a 0.2% bovine serum albumin solution. Next, a 0.1 mg / mL solution was prepared using α-glucosidase (manufactured by Wako Pure Chemical Industries, Ltd.) and phosphate buffer (1/15 M, pH 7.0), and the solution was used as the bovine serum albumin solution. To obtain an α-glucosidase solution (0.04 μg / mL).
対照としては、次に示す測定値B〜Dの値を用いた。 As controls, the following measured values B to D were used.
測定値Bは、発酵液を添加しないときの値である。具体的には、実施例1に記載の発酵液の代わりにリン酸緩衝液(1/15M、pH7.0)を用いたこと以外は、測定値Aを得るための方法と同様の方法にて、測定値Bを取得した。 The measured value B is a value when no fermentation broth is added. Specifically, in the same manner as the method for obtaining the measurement value A except that a phosphate buffer (1/15 M, pH 7.0) was used instead of the fermentation broth described in Example 1. The measured value B was obtained.
測定値Cは、測定値Aのブランクである。具体的には、実施例1に記載の発酵液(80μL)と、基質水溶液(p−ニトロフェニル−α−D−グルコピラノシド、0.02M、40μL)とを混合して、37℃で20分間保持した。次に、炭酸ナトリウム水溶液(0.2M、160μL)を加えて、さらに、α−グルコシダーゼ溶液(0.04μg/mL、40μL)を加えて、対照試験液を得た。そして、その対照試験液の吸光度(400nm)を測定した。この測定で得られた結果を、測定値Cとする。 The measurement value C is a blank of the measurement value A. Specifically, the fermentation liquid (80 μL) described in Example 1 and a substrate aqueous solution (p-nitrophenyl-α-D-glucopyranoside, 0.02 M, 40 μL) are mixed and held at 37 ° C. for 20 minutes. did. Next, an aqueous sodium carbonate solution (0.2 M, 160 μL) was added, and an α-glucosidase solution (0.04 μg / mL, 40 μL) was further added to obtain a control test solution. Then, the absorbance (400 nm) of the control test solution was measured. The result obtained by this measurement is defined as a measurement value C.
測定値Dは、測定値Bのブランクである。具体的には、リン酸緩衝液(1/15M、pH7.0、80μL)と、基質水溶液(p−ニトロフェニル−α−D−グルコピラノシド、0.02M、40μL)とを混合して、37℃で20分間保持した。次に、炭酸ナトリウム水溶液(0.2M、160μL)を加えて、さらに、α−グルコシダーゼ溶液(0.04μg/mL、40μL)を加えて、対照試験液を得た。そして、その対照試験液の吸光度(400nm)を測定した。この測定で得られた結果を、測定値Dとする。 The measurement value D is a blank of the measurement value B. Specifically, a phosphate buffer (1/15 M, pH 7.0, 80 μL) and a substrate aqueous solution (p-nitrophenyl-α-D-glucopyranoside, 0.02 M, 40 μL) were mixed, and the mixture was mixed at 37 ° C. For 20 minutes. Next, an aqueous sodium carbonate solution (0.2 M, 160 μL) was added, and an α-glucosidase solution (0.04 μg / mL, 40 μL) was further added to obtain a control test solution. Then, the absorbance (400 nm) of the control test solution was measured. The result obtained by this measurement is defined as a measurement value D.
各乳酸菌別および発酵前後における測定値A〜Dの値と、下記式(II)とを用いて、α−グルコシダーゼ阻害率を算出した。結果は、下記実施例4における表2に示す。なお、本測定は、三重測定(1群あたりn=3)によるものである。 The α-glucosidase inhibition rate was calculated using the measured values A to D before and after fermentation for each lactic acid bacterium and the following formula (II). The results are shown in Table 2 in Example 4 below. This measurement is based on a triple measurement (n = 3 per group).
なお、発酵前のα−グルコシダーゼ阻害率については、上記実施例1に記載の発酵液の代わりに、発酵前の破砕物を濾過して得られた発酵前溶液を用いた以外は、上記と同様の方法で算出した。 In addition, about the alpha-glucosidase inhibition rate before fermentation, it replaced with the fermentation liquid of the said Example 1, and the same as the above except having used the pre-fermentation solution obtained by filtering the crushed material before fermentation. It was calculated by the method.
(実施例4:測定結果)
実施例2〜3で求めた結果を表2に示す。なお、表2の値は、平均値±標準偏差を示している。
(Example 4: measurement results)
The results obtained in Examples 2-3 are shown in Table 2. In addition, the value of Table 2 has shown the average value +/- standard deviation.
表2によれば、発酵後のチロシナーゼ阻害率およびα−グルコシダーゼ阻害率は、すべての菌種において、発酵前よりも数値が大きくなっていることが分かる。つまり、酵素阻害活性等の生理活性を、発酵によって大きくすることが可能であることが分かる。 According to Table 2, it can be seen that the tyrosinase inhibition rate and the α-glucosidase inhibition rate after fermentation are larger in numerical values than before fermentation in all bacterial species. That is, it can be seen that physiological activities such as enzyme inhibitory activity can be increased by fermentation.
特に、チロシナーゼ阻害率(阻害活性)では、ビフィドバクテリウム属およびバチルス属の乳酸菌による発酵によって、その阻害率(阻害活性)が大きくなっており、ビフィドバクテリウム・ロンガムで発酵させた場合には、発酵前の6倍以上の活性を示している。また、α−グルコシダーゼ阻害率(阻害活性)においては、どの乳酸菌を用いた発酵でも、発酵後の阻害率が発酵前の約2倍となっている。 In particular, the inhibition rate (inhibitory activity) of tyrosinase is increased by the fermentation with Bifidobacterium and Bacillus lactic acid bacteria. Shows 6 times more activity than before fermentation. Moreover, in the α-glucosidase inhibition rate (inhibitory activity), in any fermentation using any lactic acid bacterium, the inhibition rate after fermentation is about twice that before fermentation.
本発明のナスに微生物を作用させて得られるナス発酵物は、優れたチロシナーゼ阻害作用、α−グルコシダーゼ阻害作用およびエラスターゼ阻害作用を有するため有用である。このような機能を有するナス発酵物は、食品や医薬品等の経口用組成物の原料として、または化粧品等の経皮用組成物の原料として利用することができるため、有用である。
The fermented eggplant obtained by allowing microorganisms to act on the eggplant of the present invention is useful because it has an excellent tyrosinase inhibitory action, α-glucosidase inhibitory action and elastase inhibitory action. The fermented eggplant having such a function is useful because it can be used as a raw material for oral compositions such as foods and pharmaceuticals or as a raw material for transdermal compositions such as cosmetics.
Claims (5)
A transdermal composition containing the fermented product according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004276725A JP2006087345A (en) | 2004-09-24 | 2004-09-24 | Fermented product obtained from eggplant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004276725A JP2006087345A (en) | 2004-09-24 | 2004-09-24 | Fermented product obtained from eggplant |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006087345A true JP2006087345A (en) | 2006-04-06 |
Family
ID=36228890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004276725A Pending JP2006087345A (en) | 2004-09-24 | 2004-09-24 | Fermented product obtained from eggplant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006087345A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894005A (en) * | 2015-04-30 | 2015-09-09 | 江苏紫石微康生物科技有限公司 | Extracellular polysaccharide high-yielding lactic acid bacterium BL21, and preparation method and application thereof |
JP2018186753A (en) * | 2017-05-03 | 2018-11-29 | 織田 次男 | Manufacturing method of fermented rice powder and manufacturing method of cosmetic and the like |
US20210052486A1 (en) * | 2019-08-22 | 2021-02-25 | Glac Biotech Co., Ltd. | Skin-whitening composition with fermentation metabolite of lactic acid bacterium and applications thereof |
WO2024136441A1 (en) * | 2022-12-20 | 2024-06-27 | 건국대학교 글로컬산학협력단 | Antioxidant, anti-inflammatory, and wound-healing composition comprising kimchi lactic acid bacteria fermented product of eggplant shell extract |
-
2004
- 2004-09-24 JP JP2004276725A patent/JP2006087345A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104894005A (en) * | 2015-04-30 | 2015-09-09 | 江苏紫石微康生物科技有限公司 | Extracellular polysaccharide high-yielding lactic acid bacterium BL21, and preparation method and application thereof |
JP2018186753A (en) * | 2017-05-03 | 2018-11-29 | 織田 次男 | Manufacturing method of fermented rice powder and manufacturing method of cosmetic and the like |
US20210052486A1 (en) * | 2019-08-22 | 2021-02-25 | Glac Biotech Co., Ltd. | Skin-whitening composition with fermentation metabolite of lactic acid bacterium and applications thereof |
WO2024136441A1 (en) * | 2022-12-20 | 2024-06-27 | 건국대학교 글로컬산학협력단 | Antioxidant, anti-inflammatory, and wound-healing composition comprising kimchi lactic acid bacteria fermented product of eggplant shell extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8257761B2 (en) | Polyphenol-containing products | |
US20090110671A1 (en) | Agent for enhanching the production of collagen and it's use | |
EP3564382B1 (en) | Fermented product and production method therefor | |
JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
JP4624742B2 (en) | Fermented material obtained from perilla leaves | |
JP4387903B2 (en) | Fermented material obtained from papaya | |
JP2006089407A (en) | Fermented product obtained from kiwi | |
JP2005307150A (en) | β-glucan | |
JP2008179601A (en) | Cosmetic composition containing bacterium of genus lactobacillus | |
JP4520386B2 (en) | Fermented matter obtained from garlic | |
KR20190079514A (en) | Cosmetic composition for skin moisturizing comprising fermented aloe as effective component | |
JP2006076925A (en) | Fermented material obtained from tomato | |
JP2006075084A (en) | Fermented product obtained from celery | |
TW201034584A (en) | Process for producing γ-aminobutyric acid-rich material | |
JP4492956B2 (en) | Fermented acerola | |
JP2019033758A (en) | Lactic acid bacteria fermented product from brassicaceae plants, and food, cosmetic and epithelial barrier enhancer containing the fermented product, as well as method for producing the fermented product | |
JP2004189718A (en) | Fermented material containing citrus fruit peel | |
KR101409764B1 (en) | Comprising lactic acid fermentation product of Gelidium amansil extract as an Active Ingredient for Improving Skin Wrinkle | |
JP2006075083A (en) | Fermented product obtained from balsam pear | |
EP2123290A1 (en) | Melanogenesis inhibitory composition | |
JP2006089408A (en) | Fermented product obtained from lemon | |
JP2006076927A (en) | Fermented material obtained from mango | |
JP6462987B2 (en) | Fermented lactic acid bacteria of cruciferous plants, food containing the fermented product, cosmetics and epithelial barrier enhancer, and method for producing the fermented product | |
JP2006199591A (en) | Lever function-improving agent | |
JP2006182654A (en) | Body fat accumulation suppressing or reducing agent |